C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 21.1 NOK Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Carasent ASA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Carasent ASA
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Cost of Revenue
-kr43.8m
CAGR 3-Years
-35%
CAGR 5-Years
-40%
CAGR 10-Years
5%
N
Nordhealth AS
OSE:NORDH
Cost of Revenue
-€5.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Cost of Revenue
-kr32m
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
23.26 NOK
Undervaluation 9%
Intrinsic Value
Price
C

See Also

What is Carasent ASA's Cost of Revenue?
Cost of Revenue
-43.8m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Cost of Revenue amounts to -43.8m NOK.

What is Carasent ASA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
5%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Carasent ASA have been -35% over the past three years , -40% over the past five years , and 5% over the past ten years .

Back to Top